Shree Ganesh Remedies Limited said that the company has developed a certain form of Cyclo-Propyl derivative, which is presently being imported by most of the manufacturers in India for the synthesis of drugs such as Naltrexone and Buprenorphine.

The API intermediates and fine chemicals producer said that the Cyclo-Propyl derivative has been developed in its laboratory located at Ankleshwar in Gujarat.

Shree Ganesh Remedies said that its product will serve domestic as well as global markets.

The Gujarat-based company expects to begin commercial production of the Cyclo-Propyl derivative by the first week of next month.

Shree Ganesh Remedies stated: “As it a basic building block we expect that it will find usage over a wide range of applications and will attract huge volumes in upcoming years.”

  Buprenorphin, Cyclo-Propyl, Gujarat, India, Naltrexone, Shree Ganesh Remedies Limited